Agilon Health, Inc. $AGL Shares Sold by Voleon Capital Management LP

Key Points

• Voleon Capital Management LP significantly reduced its holdings in Agilon Health by 56.7%, selling 265,088 shares and retaining only 202,369 shares valued at approximately $876,000.
• Multiple institutional investors, including Goldman Sachs and AQR Capital Management, adjusted their positions in Agilon Health, with AQR increasing its stake by 243.3%.
• Analysts have recently lowered their target prices for Agilon Health, with most consensus ratings at "Hold" and an average target price of $3.07, reflecting a cautious outlook for the company's performance.

Voleon Capital Management LP reduced its holdings in Agilon Health, Inc. (NYSE:AGL - Free Report) by 56.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 202,369 shares of the company's stock after selling 265,088 shares during the period. Voleon Capital Management LP's holdings in Agilon Health were worth $876,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in AGL. Raymond James Financial Inc. purchased a new position in shares of Agilon Health in the 4th quarter worth $33,000. Dimensional Fund Advisors LP boosted its stake in shares of Agilon Health by 25.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 255,914 shares of the company's stock worth $486,000 after purchasing an additional 51,852 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Agilon Health by 41.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock worth $644,000 after purchasing an additional 98,377 shares during the period. Northern Trust Corp boosted its stake in shares of Agilon Health by 13.0% during the 4th quarter. Northern Trust Corp now owns 2,962,350 shares of the company's stock worth $5,628,000 after purchasing an additional 340,304 shares during the period. Finally, Schonfeld Strategic Advisors LLC boosted its stake in shares of Agilon Health by 102.1% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 88,503 shares of the company's stock worth $168,000 after purchasing an additional 44,703 shares during the period.

Agilon Health Stock Up 2.3%

Shares of NYSE AGL traded up $0.03 during trading hours on Monday, hitting $1.10. 2,013,439 shares of the stock were exchanged, compared to its average volume of 7,142,033. The company has a market cap of $453.79 million, a PE ratio of -1.42 and a beta of 0.12. The firm has a fifty day moving average price of $1.55 and a 200-day moving average price of $2.74. Agilon Health, Inc. has a 12 month low of $0.71 and a 12 month high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The firm had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The company's revenue was down 5.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.07) EPS. As a group, equities analysts anticipate that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on AGL. Evercore ISI dropped their price target on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. Sanford C. Bernstein reaffirmed a "market perform" rating and set a $1.40 price target (down from $4.00) on shares of Agilon Health in a research note on Wednesday, August 20th. Benchmark dropped their price target on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Jefferies Financial Group dropped their price target on shares of Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a research note on Friday, August 15th. Finally, Robert W. Baird lowered their price objective on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Agilon Health presently has a consensus rating of "Hold" and an average price target of $3.07.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.